Please assess the completion status of the following clinical trial:

Trial Title: A STEP for Patients Prior to Undergoing TAVR: A Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All adult patients scheduled to undergo first-time elective TAVR~Exclusion Criteria:~* Vulnerable populations including prisoners, pregnant females and patients less than 18 years age.~* Patients with history of unstable angina, myocardial infarction, or decompensated heart failure in the week prior to screening~* Patients with physical limitations (i.e. debilitating stroke, amputation, unable to complete initial screening frailty profile)~* Patients with advanced dementia or cognitive deficits (i.e. unable to follow instructions of initial screening frailty profile)~* Exercise-induced arrhythmias

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Supervised TAVR Exercise Program (STEP) (Type: EXPERIMENTAL): Subjects in the experimental arm will participate in an individualized 4-week STEP prior to undergoing TAVR. All subjects will undergo serial frailty assessments by a blinded research assistant at baseline, pre-TAVR, and 30-days post-TAVR.
- Standard of Care (Type: NO_INTERVENTION): Subjects in the no intervention arm will proceed with their TAVR after a minimum 4 weeks without an exercise intervention. All subjects will undergo serial frailty assessments by a blinded research assistant at baseline, pre-TAVR, and 30-days post-TAVR.

Based on this trial design, predict the completion outcome and termination type (if applicable).